{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:08:16Z","timestamp":1777720096435,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.radonc.2024.110571","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T09:49:01Z","timestamp":1728553741000},"page":"110571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect"],"prefix":"10.1016","volume":"201","author":[{"given":"Zhiying","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangying","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit-Ian","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110571_b0005","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110571_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2024.110571_b0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.6004\/jnccn.2017.0121","article-title":"Validation of the 8th edition of the UICC\/AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era","volume":"15","author":"Tang","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2024.110571_b0020","article-title":"Pretreatment plasma EBV-DNA load guides induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer: a meta-analysis","volume":"10","author":"Lai","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112758","article-title":"Chemotherapy and chemo-resistance in nasopharyngeal carcinoma","volume":"207","author":"Guan","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.radonc.2024.110571_b0030","unstructured":"NCCN Clinical Practice Guidelines. NCCN clinical practice guidelines in oncology: head and neck cancers, version 3.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf; 2024 [Accessed 17 April 2024]."},{"key":"10.1016\/j.radonc.2024.110571_b0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0040","article-title":"Induction chemotherapy in nasopharyngeal carcinoma- A systematic review of phase III clinical trials","volume":"32","author":"Nazeer","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.radonc.2024.110571_b0045","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.22.00327","article-title":"Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: a multicenter, randomized phase III trial","volume":"40","author":"Zhang","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0050","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-021-21043-4","article-title":"Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2024.110571_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oraloncology.2017.04.015","article-title":"Establishing and applying nomograms based on the 8th edition of the UICC\/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy","volume":"69","author":"Xu","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0060","doi-asserted-by":"crossref","first-page":"e2029882","DOI":"10.1001\/jamanetworkopen.2020.29882","article-title":"Development of a nomogram model for treatment of nonmetastatic nasopharyngeal carcinoma","volume":"3","author":"Zhang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2024.110571_b0065","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-18-3065","article-title":"Prognostic value of deep learning PET\/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma","volume":"25","author":"Peng","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2024.110571_b0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/djaa149","article-title":"A prognostic predictive system based on deep learning for locoregionally advanced nasopharyngeal carcinoma","volume":"113","author":"Qiang","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2024.110571_b0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.21037\/atm-22-33","article-title":"Survival impact of additional induction chemotherapy in nasopharyngeal carcinoma with chronic hepatitis B infection: a retrospective, bi-center study","volume":"10","author":"Li","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2024.110571_b0080","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110571_b0085","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamaoncol.2022.2810","article-title":"Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China","volume":"8","author":"Qiao","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0090","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s00330-022-09201-8","article-title":"A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma","volume":"33","author":"Jiang","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2024.110571_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103522","article-title":"A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study","volume":"70","author":"Zhong","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.radonc.2024.110571_b0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0962280215623981","article-title":"Identification of predicted individual treatment effects in randomized clinical trials","volume":"27","author":"Lamont","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.radonc.2024.110571_b0105","article-title":"Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects","volume":"363","author":"Kent","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2024.110571_b0110","unstructured":"Shalit U, Johansson FD, Sontag D. Estimating individual treatment effect: generalization bounds and algorithms. arXiv:1606039762016. https:\/\/doi.org\/10.48550\/arXiv.1606.03976."},{"key":"10.1016\/j.radonc.2024.110571_b0115","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.2147\/JIR.S366922","article-title":"RuleFit-based nomogram using inflammatory indicators for predicting survival in nasopharyngeal carcinoma, a Bi-center study","volume":"15","author":"Luo","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.radonc.2024.110571_b0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2018.11.001","article-title":"The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy","volume":"131","author":"Wan","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0125","series-title":"Learning patient-specific cancer survival distributions as a sequence of dependent regressors","first-page":"1845","author":"Yu","year":"2011"},{"key":"10.1016\/j.radonc.2024.110571_b0130","doi-asserted-by":"crossref","first-page":"djv291","DOI":"10.1093\/jnci\/djv291","article-title":"Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma","volume":"108","author":"Tang","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2024.110571_b0135","unstructured":"Predicted Individual Treatment Effect of Induction Chemotherapy for Nasopharyngeal Carcinoma. https:\/\/npc2ite.shinyapps.io\/shinyite\/; 2024 [Accessed 17 April 2024]."},{"key":"10.1016\/j.radonc.2024.110571_b0140","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1007\/s00330-022-08864-7","article-title":"Value of skull base invasion subclassification in nasopharyngeal carcinoma: implication for prognostic stratification and use of induction chemotherapy","volume":"32","author":"Li","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2024.110571_b0145","first-page":"2184","article-title":"Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence","volume":"45","author":"Dahabreh","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.radonc.2024.110571_b0150","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2015.08.003","article-title":"The prognostic value of plasma epstein-barr viral DNA and tumor response to neoadjuvant chemotherapy in advanced-stage nasopharyngeal carcinoma","volume":"93","author":"Liu","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110571_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106230","article-title":"Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma","volume":"135","author":"Quan","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0160","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jmri.27515","article-title":"Grading soft tissue involvement in nasopharyngeal carcinoma using network and survival analyses: a two-center retrospective study","volume":"53","author":"Dong","year":"2021","journal-title":"J Magnetic Resonance Imaging : JMRI"},{"key":"10.1016\/j.radonc.2024.110571_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2019.01.021","article-title":"Subclassification of skull-base invasion for nasopharyngeal carcinoma using cluster, network and survival analyses: A double-center retrospective investigation","volume":"134","author":"Li","year":"2019","journal-title":"Radiother Oncol: J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.12.020","article-title":"Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma","volume":"42","author":"Du","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2024.110571_b0175","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3389\/fonc.2019.01343","article-title":"Selection and validation of induction chemotherapy beneficiaries among patients with T3N0, T3N1, T4N0 nasopharyngeal carcinoma using epstein-barr virus DNA: a joint analysis of real-world and clinical trial data","volume":"9","author":"Xu","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0180","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/jmri.28435","article-title":"MRI-based metastatic nodal number and associated nomogram improve stratification of nasopharyngeal carcinoma patients: potential indications for individual induction chemotherapy","volume":"57","author":"Zhao","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2024.110571_b0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2019.04.025","article-title":"Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis","volume":"137","author":"Yao","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110571_b0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2018.02.027","article-title":"Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: a systematic review and meta-analysis","volume":"129","author":"Tan","year":"2018","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024035497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024035497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T19:19:30Z","timestamp":1732303170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024035497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"alternative-id":["S0167814024035497"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110571","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110571"}}